Blood Markers Linked to Severe COVID-19 Could Pave Way for Simple Diagnostic Tests
Scientists have identified unique “indicators” in the blood of patients with severe and fatal COVID, paving the way for simple diagnostic tests to help doctors identify who will go on to become critically ill. More...23 Dec 2021
Bio-Rad Launches Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays
Bio-Rad Laboratories, Inc. (Hercules, CA, USA) has launched Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays that allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of the SARS-CoV-2 virus. More...21 Dec 2021
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
FLU/RSV Test
Humasis FLU/RSV Combo
In Other News
Sugar-Coated COVID-19 Test Strip Detects All Known Coronavirus Variants
New Diagnostic Combines Fast Imaging Hardware with Data Analysis to Indicate Blood Clotting in COVID-19 Patients
New Test Developed Using AI Proves Almost 100% Accurate in Detecting COVID-19 Antibodies
Seegene Launches New PCR Test that Identifies Omicron, Its Stealth Version, and All VOCs in Single Tube
New Saliva-Based COVID-19 Antigen Rapid Test Delivers Results in Minutes with Nearly Comparable Sensitivity to PCR Test
Lab-Based COVID-19 PCR Tests Fail to Distinguish New ‘Stealth’ Version of Omicron from Other Variants
Blood-Based Biomarker Test Could Identify Patients at High Risk of Severe COVID-19
Rapid COVID-19 Test Compares Solidly With PCR Detection in Largest Field Hospital Study
Biomérieux Molecular Tests Amplify and Detect SARS-CoV-2 Omicron Variant
Seegene’s High Multiplex PCR Assay Can Detect New Omicron Variant
New Biomarker Can Predict COVID-19 Severity by Means of a Blood Test
New Study Identifies Impact of Sample Processing on Sensitivity of Rapid Antigen Detection Tests for SARS-CoV-2
New COVID-19 Rapid Test Identifies Antibody Effectiveness Against Multiple SARS-CoV-2 Variants
Qiagen Launches CE-marked Version of QuantiFERON SARS-CoV-2 to Assess T-cell Response to COVID-19
New Metabolism-Based Blood Test Predicts COVID-19 Severity and Risk
New 1-Minute COVID-19 Saliva Test Enables Swift Diagnosis of SARS-CoV-2 Infection
Randox Leads UK’s International Travel Testing Efforts in Response to New Omicron Variant
Eurofins Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A/B, and RSV A/B
High-Volume PCR and Rapid Antigen Tests Unlikely to Be Impacted by New Omicron Variant, Says US FDA
Measuring Antibodies in Saliva a Useful and Easy Strategy to Detect SARS-CoV-2 Infections, Finds Study
Compact CRISPR System Enables Portable COVID-19 Testing
New Device Detects Viruses Like COVID-19 in the Body as Fast as Rapid Tests With 95% Accuracy
Only Saliva-Based Rapid COVID-19 Test in the Market Delivers Highly Accurate Results in 15 Minutes at POC
